Tools

LEADER 03226cam 2200553 i 4500

001 on1202808900;

003 OCoLC;

005 20210312143229.0;

006 m o d f ;

007 cr |||||||||||;

008 201104s2020 dcua ob f000 0 eng c;

019 a| 1227258054;

024 8 a| 39-747q| (GPO jacket number);

042 a| pcc;

043 a| n-us---;

049 a| ERE#;

050 4 a| KF27b| .E5546 2019e;

074 a| 1019-C-01 (online);

086 0 a| Y 4.C 73/8:116-25;

088 a| Serial no. 116-25 (United States. Congress. House. Committee on Energy and Commerce);

245 10 a| Priced out of a lifesaving drug :b| getting answers on the rising cost of insulin : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Sixteenth Congress, first session, April 10, 2019.;

246 30 a| Getting answers on the rising cost of insulin;

264 1 a| Washington :b| U.S. Government Publishing Office,c| 2020.;

300 a| 1 online resource (v, 211 pages) :b| illustration;

336 a| textb| txt2| rdacontent;

337 a| computerb| c2| rdamedia;

338 a| online resourceb| cr2| rdacarrier;

500 a| Access ID (govinfo): CHRG-116hhrg39747.;

500 a| "Serial No. 116-25.";

500 a| GPO Cataloging Record Distribution Program (CRDP).;

504 a| Includes bibliographical references.;

511 0 a| Hearing witnesses: Michael B. Mason, Senior Vice President, Lilly Connected Care and Insulins Global Business Unit, Eli Lilly and Company; Douglas J. Langa, Executive Vice President, North America Operations, and President of Novo Nordisk Inc; Kathleen W. Tregoning, Executive Vice President for External Affairs, Sanofi; Thomas M. Moriarty, Executive Vice President, Chief Policy and External Affairs Officer and General Counsel, CVS Health; Amy Bicker, R.Ph., Senior Vice President, Supply Chain, Express Scripts; Sumit Dutta, M.D., Senior Vice President and Chief Medical Officer, Optumrx.;

518 a| Date of hearing: 2019-04-10.;

588 a| Description based on online resource; title from PDF title (govinfo, viewed Nov. 1, 2020).;

650 0 a| Prescription pricingx| Government policyz| United States.=| ^A63214;

650 0 a| Pharmaceutical industryx| Government policyz| United States.=| ^A3655;

650 0 a| Drugsz| United Statesx| Cost control.=| ^A640;

655 7 a| Legislative hearings.2| lcgft;

776 08 i| Print version:a| United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Oversight and Investigations.t| Priced out of a lifesaving drugw| (OCoLC)1202808915;

856 40 u| https://purl.fdlp.gov/GPO/gpo146986;

922 a| GOVINFOHRG;

922 a| BIBCONEWb| 20201104;

949 a| Click on web addressw| asish| joyner94;

596 a| 1;

998 a| 5536115;

999 a| CLICK ON WEB ADDRESSw| ASISc| 1i| 5536115-1001l| JNETm| JOYNERr| Ys| Yt| JNE1DOu| 12/11/2020x| EDOCUMENTz| JERESOURCE;

Priced out of a lifesaving drug : getting answers on the rising cost of insulin : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Sixteenth Congress, first session, April 10, 2019.

Author/creator	United States
Format	Electronic
Publication	Washington : U.S. Government Publishing Office, 2020.
Description	1 online resource (v, 211 pages) : illustration
Supplemental Content	https://purl.fdlp.gov/GPO/gpo146986
Subjects	Prescription pricing--Government policy. --United States. Pharmaceutical industry--Government policy. --United States. Drugs--United States. --Cost control. Drugs--Prices. --Health aspects. --United States.

Portion of title	Getting answers on the rising cost of insulin
General note	Access ID (govinfo): CHRG-116hhrg39747.
General note	"Serial No. 116-25."
General note	GPO Cataloging Record Distribution Program (CRDP).
Bibliography note	Includes bibliographical references.
Performer	Hearing witnesses: Michael B. Mason, Senior Vice President, Lilly Connected Care and Insulins Global Business Unit, Eli Lilly and Company; Douglas J. Langa, Executive Vice President, North America Operations, and President of Novo Nordisk Inc; Kathleen W. Tregoning, Executive Vice President for External Affairs, Sanofi; Thomas M. Moriarty, Executive Vice President, Chief Policy and External Affairs Officer and General Counsel, CVS Health; Amy Bicker, R.Ph., Senior Vice President, Supply Chain, Express Scripts; Sumit Dutta, M.D., Senior Vice President and Chief Medical Officer, Optumrx.
Date/time/place of a event note	Date of hearing: 2019-04-10.
Source of description	Description based on online resource; title from PDF title (govinfo, viewed Nov. 1, 2020).
Issued in other form	Print version: United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Oversight and Investigations. Priced out of a lifesaving drug
Genre/form	Legislative hearings.
Standard identifier#	39-747 (GPO jacket number)
Technical rpt number	Serial no. 116-25 (United States. Congress. House. Committee on Energy and Commerce)
GPO item number	1019-C-01 (online)
Govt. docs number	Y 4.C 73/8:116-25

Availability

Library	Location	Call Number	Status	Item Actions
	Electronic Resources	Access Content Online	✔ Available

Priced out of a lifesaving drug : getting answers on the rising cost of insulin : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Sixteenth Congress, first session, April 10, 2019.

Click here for more information about this title

Availability